| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/25/2007 | CN1953736A Drug delivery system based on immune response system |
| 04/25/2007 | CN1953664A Anti-microbial activity of biologically stabilized silver nano particles |
| 04/25/2007 | CN1951982A Preparation method of polyethylene imine nanometer gelatin |
| 04/25/2007 | CN1951978A Carbowax modifier of nicotinic acid and its synthesis method |
| 04/25/2007 | CN1951962A Polypeptide for preparing antineoplastic antibody and its uses |
| 04/25/2007 | CN1951502A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/25/2007 | CN1951501A Pharmaceutical composition with Meclofenoxate hydrochloride capable of preventing hydrolysis |
| 04/25/2007 | CN1951500A Colouring application of pearly pigment in medicine |
| 04/25/2007 | CN1951498A A fibroid magnetic medicament and preparation method thereof |
| 04/25/2007 | CN1951495A Nano target medicine for magnetothermal therapy of malignant tumor |
| 04/25/2007 | CN1951459A Medicament for matching with holographic fire burning therapy in acupoints and preparation method thereof |
| 04/25/2007 | CN1951393A Hydrophobic formulation containing total notoginseng glycosides and phospholipid and preparation method thereof |
| 04/25/2007 | CN1951391A Method for preparing suspension of rhodiola root nanoliposome |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951383A Stabilized medical and cosmetic composition containing catechin |
| 04/25/2007 | CN1951381A Baicalin solution composition |
| 04/25/2007 | CN1951372A Solid oral dosage forms comprising valsartan and HCTZ |
| 04/25/2007 | CN1951371A Immediate release tablet |
| 04/25/2007 | CN1951369A Coated nanoliposomes of resveratrol and preparation method thereof |
| 04/25/2007 | CN1951367A Fat emulsion containing hydroxycamptothecine and preparation method thereof |
| 04/25/2007 | CN1312199C Method for preparing variable suspensoid effect from fine particles sensitive to temperature |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1311873C Temperature sensitive gel formulation for in situ vagina uses |
| 04/25/2007 | CN1311865C Prolonged delivery of peptides |
| 04/25/2007 | CN1311835C Pharmaceutical parenteral composition containing biphosphonate |
| 04/25/2007 | CN1311831C Antibacterial medicinal composition of enhanced oral absorptivity |
| 04/25/2007 | CN1311823C Indirubin phosphatide compound and its preparation method |
| 04/25/2007 | CN1311819C Crystalline composition containing escitalopram |
| 04/25/2007 | CA2524422A1 A gastric retention drug delivery system |
| 04/24/2007 | US7208615 Preferred salts are triple metal salts of calcium, magnesium or zinc and potassium; tasteless, odorless and highly water soluble; used in beverages, neutraceuticals and for treating obesity |
| 04/24/2007 | US7208612 Crystals of LuxP and complexes thereof |
| 04/24/2007 | US7208594 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds, |
| 04/24/2007 | US7208593 Self-cross-linked alkyl cellulose |
| 04/24/2007 | US7208556 Comonomers of alkali, alkaline earth metal or ammonium salt of (meth)acrylamidoalkylsulfonic acid; cyclic N-vinylcarboxamides and/or linear N-vinylcarboxamides and crosslinker; terpolymer of 2-acrylamido-2-methylpropanesulfonic acid, N-vinylpyrrolidone and allyl methacrylate; cosmetics |
| 04/24/2007 | US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/24/2007 | US7208483 Polymeric delivery agents and delivery agent compounds |
| 04/24/2007 | US7208478 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/24/2007 | US7208471 Glycopeptide phosphonate derivatives |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208179 Preparing a supplemented tissue sealant, applying to patient |
| 04/24/2007 | US7208178 For facilitating the delivery of active agents, such as insulin, to a target |
| 04/24/2007 | US7208177 Resorbable extracellular matrix for reconstruction of cartilage |
| 04/24/2007 | US7208174 Liposome compositions |
| 04/24/2007 | US7208171 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 04/24/2007 | US7208166 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology |
| 04/24/2007 | US7208160 Process of treating sea algae and halophytic plants |
| 04/24/2007 | US7208156 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 04/24/2007 | US7208148 Chemically modified cytokines |
| 04/24/2007 | US7208145 Polymeric reagents comprising a ketone or a related functional group |
| 04/24/2007 | US7208141 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections |
| 04/24/2007 | CA2344678C Semi-moist oral delivery system |
| 04/24/2007 | CA2309688C Penetration enhancing and irritation reducing systems |
| 04/24/2007 | CA2301711C Lipid-containing compositions and uses thereof |
| 04/24/2007 | CA2301135C Rapidly disintegrating methylcellulose tablets |
| 04/24/2007 | CA2264105C Granulates comprising a water soluble compound and cellulose |
| 04/24/2007 | CA2254848C Methods for sterilizing male mammals |
| 04/24/2007 | CA2138451C Sugar-coated pharmaceutical dosage unit |
| 04/24/2007 | CA2106827C Pharmaceutical compositions containing cyclosporins |
| 04/20/2007 | CA2562249A1 Anf analogue |
| 04/19/2007 | WO2007044892A2 Upar-binding molecule-drug conjugates and uses thereof |
| 04/19/2007 | WO2007044681A2 Reduction of saltiness with sweeteners |
| 04/19/2007 | WO2007044608A2 Fiber satiety compositions |
| 04/19/2007 | WO2007044559A1 System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids |
| 04/19/2007 | WO2007044476A2 Lysozyme fortified milk and milk products |
| 04/19/2007 | WO2007044375A2 Pth formulations and methods of use |
| 04/19/2007 | WO2007044069A2 Pth formulations and methods of use |
| 04/19/2007 | WO2007043715A1 Rna-binding peptide |
| 04/19/2007 | WO2007043702A1 Agent for applying to mucosa and method for production thereof |
| 04/19/2007 | WO2007043605A1 Iontophoresis apparatus sticking to mucosa |
| 04/19/2007 | WO2007043538A1 Composition for oral administration |
| 04/19/2007 | WO2007043486A1 Biocompatible block copolymer, use thereof, and production method thereof |
| 04/19/2007 | WO2007043429A1 Face head pad for iontophoresis device, and iontophoresis apparatus comprising the same |
| 04/19/2007 | WO2007043057A2 Compositions for nasal delivery |
| 04/19/2007 | WO2007043050A2 Bioconjugates comprising sulfated polysaccharides and their uses |
| 04/19/2007 | WO2007042833A2 Arnphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents |
| 04/19/2007 | WO2007042775A2 Conjugates of photosensitisers and antibodies |
| 04/19/2007 | WO2007042682A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
| 04/19/2007 | WO2007042470A2 Antithrombotic compound |
| 04/19/2007 | WO2007042469A2 Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 04/19/2007 | WO2007042281A2 Processing of chitosan and chitosan derivatives |
| 04/19/2007 | WO2007041861A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 04/19/2007 | WO2007019845A3 Method for encapsulating therapeutic substances in cells |
| 04/19/2007 | WO2007015270A3 Novel controlled release compositions of selective serotonin reuptake inhibitors |
| 04/19/2007 | WO2007012807A3 Dna structures |
| 04/19/2007 | WO2007012625A8 Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 04/19/2007 | WO2007012539A3 Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 04/19/2007 | WO2007009012A3 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
| 04/19/2007 | WO2006105741B1 Topical pharmaceutical formulation containing nimesulide |
| 04/19/2007 | WO2006088972A3 Use of modulatirs of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism |
| 04/19/2007 | WO2006087196A3 Methods for treating cancer using an immunotoxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer-associated protease site cleaved by mmp-2 or mmp-9 |
| 04/19/2007 | WO2005085458A3 Polyacetal-peptide mediated transfection |
| 04/19/2007 | WO2005076697A3 Cosmetic and pharmaceutical foam with solid matter |
| 04/19/2007 | WO2004099375A3 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070088435 Nitrosation of a organosulfur polymer; coating medical equipment such as tubes, catheters |
| 04/19/2007 | US20070088060 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates |
| 04/19/2007 | US20070087999 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 04/19/2007 | US20070087961 Conjugates of hydroxyalkyl starch and erythropoietin |
| 04/19/2007 | US20070087958 Compounds and compositions for delivering active agents |
| 04/19/2007 | US20070087390 Opiate, cannabinoid, and estrogen receptors |